USTR SEEKS COMMENTS ON THE EXTENSION OF CHINA 301 TARIFF EXCLUSIONS ON CERTAIN MEDICAL CARE PRODUCTS
In a Federal Register Notice of August 27, 2021, the Office of the U.S. Trade Representative (“USTR”) announced that it is seeking comments on the extension of existing China 301 exclusions on certain medical care products.
On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending certain expiring China 301 tariff exclusions on medical care products and designating certain additional such exclusions for the period January 1, 2021 through March 31, 2021. Such exclusions (99 in total) were extended through September 30, 2021.
On June 15, 2026, the Supreme Court of the United States denied a petition for certiorari in HTMX Industries, LLC, et al., the lead case challenging the imposition of additional
The United States Trade Representative (USTR) has published notice of its intent to impose additional duties on products from 60 countries, stemming from its investigation under Section 301 of the
GDLSK Partner Arthur Bodek will participate as a panelist at the International Trade Compliance Professionals Association 2026 Canada Conference being held in
Insights, News
USTR SEEKS COMMENTS ON THE EXTENSION OF CHINA 301 TARIFF EXCLUSIONS ON CERTAIN MEDICAL CARE PRODUCTS
In a Federal Register Notice of August 27, 2021, the Office of the U.S. Trade Representative (“USTR”) announced that it is seeking comments on the extension of existing China 301 exclusions on certain medical care products.
On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending certain expiring China 301 tariff exclusions on medical care products and designating certain additional such exclusions for the period January 1, 2021 through March 31, 2021. Such exclusions (99 in total) were extended through September 30, 2021.
In light of various factors, including the rise in COVID-19 cases in the U.S. and the ability to obtain certain products from domestic and foreign sources, the USTR is requesting public comments on whether to extend the medical care product exclusions for up to six months. The list of the particular products in question can be found at: https://www.gdlsk.com/ustr-extends-certain-china-301-exclusions-and-designates-additional-exclusions-for-the-period-january-1-march-31-2021/?highlight=medical%20care%20products.
Comments are being accepted through September 27, 2021.
We are available to assist with the preparation of comments and to otherwise discuss China 301 mitigation strategies.
Please do not hesitate to contact Arthur Bodek or any of our attorneys for further information.
Additional News
China Section 301 Litigation Update
On June 15, 2026, the Supreme Court of the United States denied a petition for certiorari in HTMX Industries, LLC, et al., the lead case challenging the imposition of additional
USTR PROPOSES ADDITIONAL DUTIES; SETS DEADLINE FOR COMMENTS IN SECTION 301 INVESTIGATION RELATED TO FORCED LABOR
The United States Trade Representative (USTR) has published notice of its intent to impose additional duties on products from 60 countries, stemming from its investigation under Section 301 of the
Additional Insights
Arthur W. Bodek to Speak at the ICPA 2026 Canada Conference
GDLSK Partner Arthur Bodek will participate as a panelist at the International Trade Compliance Professionals Association 2026 Canada Conference being held in
Valerie Sorensen-Clark to Speak on KlearNow Tariff Webinar
GDLSK partner Valerie Sorensen-Clark will present on a live webinar on May 21 at 12:30pm ET, covering the current state of